高级检索
    金美琦, 徐慧, 朱益麟. 不同分子分型年轻乳腺癌患者的MRI特征性表现[J]. 徐州医科大学学报, 2024, 44(6): 409-414. DOI: 10.3969/j.issn.2096-3882.2024.06.004
    引用本文: 金美琦, 徐慧, 朱益麟. 不同分子分型年轻乳腺癌患者的MRI特征性表现[J]. 徐州医科大学学报, 2024, 44(6): 409-414. DOI: 10.3969/j.issn.2096-3882.2024.06.004
    JIN Meiqi, XU Hui, ZHU Yilin. Characteristic MRI manifestations of young breast cancer patients with different molecular types[J]. Journal of Xuzhou Medical University, 2024, 44(6): 409-414. DOI: 10.3969/j.issn.2096-3882.2024.06.004
    Citation: JIN Meiqi, XU Hui, ZHU Yilin. Characteristic MRI manifestations of young breast cancer patients with different molecular types[J]. Journal of Xuzhou Medical University, 2024, 44(6): 409-414. DOI: 10.3969/j.issn.2096-3882.2024.06.004

    不同分子分型年轻乳腺癌患者的MRI特征性表现

    Characteristic MRI manifestations of young breast cancer patients with different molecular types

    • 摘要: 目的 分析不同分子分型年轻乳腺癌患者MRI特征性表现。方法 选择新疆医科大学附属肿瘤医院2013年4月—2020年12月406例经病理证实的乳腺癌患者,其中年轻组乳腺癌190例(<40岁),中老年组乳腺癌216例(≥40岁),术前均接受MRI检查。对比2组患者MRI特征性表现,并比较不同分子分型年轻乳腺癌患者MRI特征及组织学分级。结果 与中老年组乳腺癌患者比较,年轻组乳腺癌患者MRI更易表现为边缘清晰、不均匀强化,早期强化率(IER)更高,表观弥散系数(ADC)值更低(P均<0.05)。年轻组乳腺癌患者中,三阴性型IER明显高于Luminal A型(P<0.05);Luminal B型ADC值高于HER-2过表达型、三阴性型(P<0.05);HER-2过表达型、三阴性型组织学分级以Ⅲ级为主,Luminal A型、Luminal B型组织学分级以Ⅱ级为主(P<0.05)。结论 年轻乳腺癌MRI表现有一定特征性,可为其临床治疗方案制定及预后评估提供参考。

       

      Abstract: Objective To analyze the characteristic MRI manifestations of young breast cancer patients with different molecular types. Methods A total of 406 patients with pathologically confirmed breast cancer who were admitted to the Affiliated Cancer Hospital of Xinjiang Medical University from April 2013 to December 2020 were selected, including 190 breast cancer patients in a young group (<40 years old) and 216 breast cancer patients in a middle-aged and elderly group (≥40 years old). All the patients underwent MRI examination before surgery. Both groups were compared for characteristic MRI manifestations. Young breast cancer patients with different molecular types were compared for MRI characteristics and histological stages. Results Compared with breast cancer patients in the middle-aged and elderly group, those in the young group were more likely to present clear margins and uneven enhancement, with increases in initial enhancement rate (IER) and decreases in apparent diffusion coefficient (ADC) values (both P<0.05). In the young group, the triple-negative type breast cancer showed significantly higher IER than the Luminal A type (P<0.05); the Luminal B type breast cancer presented higher ADC value than the HER-2 overexpression type and the triple-negative type (P<0.05); and the HER-2 overexpression type and the triple-negative type breast cancer were mainly histological stage Ⅲ, while the Luminal A type and the Luminal B type was predominantly stage Ⅱ(P<0.05). Conclusions The MRI manifestations of young breast cancer have certain characteristics, which can provide reference for the formulation of clinical treatment regimen and prognosis assessment.

       

    /

    返回文章
    返回